News tagged with cancer trials
Glowing Cornell dots -- a potential cancer diagnostic tool set for human trials
The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of a new technology: Cornell Dots, brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.
Nanotechnology / Bio & Medicine
Jun 13, 2011 |
5 / 5 (5) |
1
|
RxPONDER trial will evaluate whether gene expression test can drive chemotherapy choice
Cancer researchers at hundreds of sites nationwide are about to launch a SWOG-led clinical trial that could keep thousands of breast cancer patients from getting chemotherapy that is unlikely to do them any good.
Apr 26, 2011 |
not rated yet |
0
Vitamin A derivative can inhibit early forms of breast cancer
A nutrient found in carrots and sweet potatoes may prove key to fighting breast cancer at early stages, according to a new study by researchers at Fox Chase Cancer Center. Sandra Fernandez, PhD, an assistant research professor ...
Apr 05, 2011 |
not rated yet |
0
New target identified for squamous cell lung cancer
Scientists at the Dana Farber Cancer Institute have identified a mutation in the DDR2 gene that may indicate which patients with squamous cell lung cancer will respond to dasatinib.
Apr 03, 2011 |
not rated yet |
0
FDA considers new rules to speed up confirmatory trials of drugs granted accelerated approval
Since 1992, the U.S. Food and Drug Administration has granted accelerated approval to 47 new indications for 35 cancer drugs and in more than half the cases—26 indications—further trials have confirmed the benefits ...
Medicine & Health / Medications
Mar 25, 2011 |
not rated yet |
1
Study puts notch on the jagged edge of lung cancer metastasis
Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical In ...
Mar 14, 2011 |
5 / 5 (1) |
0
Targeted ovarian cancer therapy not cost-effective: study
An analysis conducted by Ohio State University cancer researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is not cost effective.
Mar 07, 2011 |
not rated yet |
0
UT Southwestern launches clinical trial for treatment of breast cancer using CyberKnife
Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure ...
Feb 15, 2011 |
not rated yet |
0
Few physicians refer patients to cancer clinical trials
A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute.
Feb 12, 2011 |
5 / 5 (1) |
0
Areva to begin US trial of cancer-fighting isotope
A subsidiary of the French nuclear giant Areva said Monday it had received US clearance to begin a clinical trial of an isotope that targets cancer cells.
Jan 24, 2011 |
4 / 5 (3) |
1
Unrealistic optimism appears common in early cancer trials
(Garrison, NY) Can optimism be ethically problematic? Yes, according to a new study, which found unrealistic optimism prevalent among participants in early-phase cancer trials and suggested that it may compromise informed ...
Jan 24, 2011 |
5 / 5 (1) |
1
New drug uses stealth to stop cancer cell reproduction
A new investigational drug designed to stop cancer cells from reproducing may offer hope for patients with advanced solid tumor cancers. Clinical trials of TKM-PLK1 for qualified patients are now open at the Virginia G. Piper ...
Jan 12, 2011 |
not rated yet |
0
Behavioral therapy program reduces incontinence following radical prostatectomy
For men with incontinence for at least one year following radical prostatectomy, participation in a behavioral training program that included pelvic floor muscle training, bladder control strategies and fluid management, ...
Jan 11, 2011 |
not rated yet |
0
Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear
It remains an unresolved issue as to whether interstitial brachytherapy has advantages compared to other therapy options in men with localized prostate cancer, nor do newer studies provide proof in this respect. This is the ...
Jan 11, 2011 |
not rated yet |
0
Quality of life measures in breast cancer clinical trials
Quality of life measures tend to be most useful for clinical decision-making in trials in which quality of life is the primary outcome, according to a recent study published online January 7 in The Journal of the National Ca ...
Jan 07, 2011 |
not rated yet |
0
